These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30309498)
1. Establishment and characterization of a new triple-negative canine mammary cancer cell line. Zhang H; Pei S; Zhou B; Wang H; Du H; Zhang D; Lin D Tissue Cell; 2018 Oct; 54():10-19. PubMed ID: 30309498 [TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line. Chen A; Ye S; Zheng J; Li J; Chen Z; Zhang Y; Li S BMC Vet Res; 2023 Jan; 19(1):22. PubMed ID: 36717813 [TBL] [Abstract][Full Text] [Related]
3. Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118. Gao H; Zhou H; Gao Y; He L; Li W; Xu M; Feng H; Feng X; Qiu C Vet Comp Oncol; 2022 Sep; 20(3):679-687. PubMed ID: 35429113 [TBL] [Abstract][Full Text] [Related]
4. Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026. Mei C; Xin L; Liu Y; Lin J; Xian H; Zhang X; Hu W; Xia Z; Wang H; Lyu Y Front Vet Sci; 2021; 8():744032. PubMed ID: 34712723 [TBL] [Abstract][Full Text] [Related]
5. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer. Dagher E; Simbault L; Abadie J; Loussouarn D; Campone M; Nguyen F Tumour Biol; 2020 Jan; 42(1):1010428319901052. PubMed ID: 31959092 [TBL] [Abstract][Full Text] [Related]
7. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT. Raposo LR; Roma-Rodrigues C; Faísca P; Alves M; Henriques J; Carvalheiro MC; Corvo ML; Baptista PV; Pombeiro AJ; Fernandes AR Vet Comp Oncol; 2017 Sep; 15(3):952-967. PubMed ID: 27140424 [TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a multi-drug resistant cell line for canine mammary tumors. Zhou C; Lin Z; Li X; Zhang D; Song P Front Vet Sci; 2023; 10():1129756. PubMed ID: 37077947 [TBL] [Abstract][Full Text] [Related]
9. Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin. Hellmén E; Moller M; Blankenstein MA; Andersson L; Westermark B Breast Cancer Res Treat; 2000 Jun; 61(3):197-210. PubMed ID: 10965996 [TBL] [Abstract][Full Text] [Related]
10. A Novel Canine Mammary Cancer Cell Line: Preliminary Identification and Utilization for Drug Screening Studies. Li R; Wu H; Sun Y; Zhu J; Tang J; Kuang Y; Li G Front Vet Sci; 2021; 8():665906. PubMed ID: 34124226 [TBL] [Abstract][Full Text] [Related]
11. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966 [TBL] [Abstract][Full Text] [Related]
12. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study. Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867 [TBL] [Abstract][Full Text] [Related]
14. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer? Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453 [TBL] [Abstract][Full Text] [Related]
15. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer. Antuofermo E; Miller MA; Pirino S; Xie J; Badve S; Mohammed SI Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119 [TBL] [Abstract][Full Text] [Related]
16. Current biomarkers of canine mammary tumors. Kaszak I; Ruszczak A; Kanafa S; Kacprzak K; Król M; Jurka P Acta Vet Scand; 2018 Oct; 60(1):66. PubMed ID: 30373614 [TBL] [Abstract][Full Text] [Related]
17. Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance. Abadie J; Nguyen F; Loussouarn D; Peña L; Gama A; Rieder N; Belousov A; Bemelmans I; Jaillardon L; Ibisch C; Campone M Breast Cancer Res Treat; 2018 Jan; 167(2):459-468. PubMed ID: 29063312 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model. Leonel C; Borin TF; de Carvalho Ferreira L; Moschetta MG; Bajgelman MC; Viloria-Petit AM; de Campos Zuccari DA J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):27-41. PubMed ID: 28078601 [TBL] [Abstract][Full Text] [Related]
19. [Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft]. Wang K; Xie SM; He JJ; Ren Y; Xia HB; Zhang XW Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1812-8. PubMed ID: 22126756 [TBL] [Abstract][Full Text] [Related]
20. The antiprogestins mifepristone and onapristone reduce cell proliferation in the canine mammary carcinoma cell line CMT-U27. Guil-Luna S; Hellmén E; Sánchez-Céspedes R; Millán Y; Martín de las Mulas J Histol Histopathol; 2014 Jul; 29(7):949-55. PubMed ID: 24500783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]